Replies to post #152823 on Biotech Values

[north40000]

BASF...a little more:

BASF announces cash offer to acquire Pronova BioPharma

BASF announces cash offer to acquire Pronova BioPharma
BASF to achieve leading position in omega-3 fatty acids
Cash offer of NOK 12.50 per share
Offer unanimously recommended by Pronova`s Board of Directors and management
Pre-acceptance by approximately 60% of share capital


http://finance.yahoo.com/news/basf-announces-cash-offer-acquire-060202620.html

[DewDiligence]

AMRN—...that BASF is planning to shift [Pronova’s] facilities to the manufacture of Vascepa is fairly transparent.

Nothing in BASF’s press release in #msg-81711876 suggests such a thing, IMO. Please elaborate.